Author

A. Çelik

h-index 9 View on Semantic Scholar

We have 1 of 44 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Drug survival of adalimumab across different manifestations of Behçet's syndrome: a retrospective analysis in 335 patients.

Evaluating the long-term drug survival of adalimumab in a large cohort of patients with Behçet's syndrome found a good retention rate at month 6, followed by a gradual decline in drug retention over time.

Ozge Sonmez, S. N. Esatoğlu, D. Uçar et al. · Rheumatology · 0 citations